Anti-PD-1 (PD-1 antibody) binds to CD8+ T cells, preventing the interaction between PD-1 and its ligands, thereby restoring suppressed tumor-specific T cell cytotoxicity 5. This evidence concerns the gene CD8A and neoplasm.